Imperial College London

ProfessorJustinMason

Faculty of MedicineNational Heart & Lung Institute

Head of the Cardiovascular Division
 
 
 
//

Contact

 

justin.mason Website

 
 
//

Assistant

 

Miss Natasha Richmond +44 (0)20 7594 6457

 
//

Location

 

537Block L Hammersmith HospitalHammersmith Campus

//

Summary

 

Summary

Justin Mason is Professor of Vascular Rheumatology within Vascular Sciences, National Heart and Lung Institute at  Hammersmith Hospital.

Professor Mason leads a basic science research group investigating molecular mechanisms involved in the regulation of vascular endothelial cytoprotection. A more detailed understanding of these mechanisms will facilitate the rational design of novel therapies by which vascular endothelium can be conditioned in order to minimise vascular injury, EC dysfunction and subsequent atherogenesis in patients with systemic inflammatory disease. In addition, he is actively involved in clinical research, which aims to optimise clinical assessment and treatment of the large vessel vasculitides and understand the relationship between chronic endothelial dysfunction and accelerated atherosclerosis. Read more on Justin's research.

Justin graduated in Medicine in 1986 from the University of London and trained in Rheumatology at the Kennedy Institute of Rheumatology, Charing Cross Hospital and at the Royal Postgraduate Medical School in London. Following award of a Medical Research Council Training Fellowship in 1992 and subsequently a PhD degree in 1996 from Imperial College London, he was awarded an Arthritis Research Campaign Senior Research Fellowship in 2000. He is a Fellow of the Royal College of Physicians in London and of the Association of Physicians of Great Britain and Ireland, and is the Chair of the Arthritis Research UK - Research Education and Capacity Committee, a member of the Medical Research Society Committee and the British Heart Foundation Project Grant Committee..


Publications

Journals

Tarkin JM, Wall C, Gopalan D, et al., 2020, Novel Approach to Imaging Active Takayasu Arteritis Using Somatostatin Receptor Positron Emission Tomography/Magnetic Resonance Imaging., Circ Cardiovasc Imaging, Vol:13

Porter A, Youngstein T, Tombetti E, et al., Biologic therapy in supra-aortic Takayasu arteritis can improve symptoms of cerebral ischaemia without surgical intervention, Rheumatology, ISSN:0080-2727

Mason J, The Impact of Integrated Non-invasive Imaging in the Management of Takayasu Arteritis, Jacc: Cardiovascular Imaging, ISSN:1876-7591

Dufton NP, Peghaire CR, Osuna-Almagro L, et al., 2020, Author Correction: Dynamic regulation of canonical TGFβ signalling by endothelial transcription factor ERG protects from liver fibrogenesis., Nat Commun, Vol:11

Mackie SL, Dejaco C, Appenzeller S, et al., 2020, British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary, Rheumatology, Vol:59, ISSN:1462-0324, Pages:487-494

More Publications